You are here

  • Home
  • Archive
  • Volume 82, Issue 2
  • Correction: Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis
Free

https://doi.org/10.1136/annrheumdis-2018-213590corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Shim J, Jones GT, Pathan EMI, et al. Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis. Ann Rheum Dis 2018;77:1578–84. doi:10.1136/annrheumdis-2022–213590

    The correct figure 3 and text:

    Forest plot comparing changes in WPAI outcomes between patients in the biologic and non-biologic treatment groups.

    Embedded Image

    In contrast, there was no improvement in absenteeism in either treatment group; absolute change in TNFi therapy and non-TNFi therapy groups across studies were −2.2% and −2.5%, respectively, and the pooled change in absenteeism was similar in both groups (MD=−1.59, 95% CI −5.97, 2.79) (Amended Figure 3).

    The corrected values are presented in highlight.

    Linked Articles